Provides the following healthcare services to drug users, focusing on issues that occur as a result of injecting drugs. 
- Abscess treatment and care
- Vein care consultation
- HIV/hepatitis testing and counseling 
- Hepatitis A & B vaccinations 
- TB screening
- Treatment for colds and upper respiratory infections 
- Harm reduction education
- Narcan
Offers counseling and case management as well as referrals to drug treatment and other health and social services. 
Connects users to Buprenorphine and Methadone treatment.

Injection Drug User Medical Clinic offered by Public Health - Seattle & King County at Robert Clewis Center

Provides abscess treatment and care, vein care consultation, HIV/hepatitis testing and counseling, Hepatitis A & B vaccinations and TB screening to injection drug users. Can connect them to Buprenorphine treatment. Narcan available.

Medication assisted treatment (MAT) programs that use buprenorphin to help people with an opioid use disorder abstain from or reduce their use of opioids (usually heroin or painkillers such as oxycondin or morphine). Buprenorphine produces a weaker version of effects (including euphoria and respiratory depression) that are associated with full drugs such as heroin and methadone. The effects increase with each dose until at moderate doses they level off, lowering the risk of misuse, dependency and side effects. Treatment occurs in three phases: a medically monitored start-up phase when the patient is in early stages of withdrawal; a stabilization phase after a patient has discontinued or greatly reduced their misuse of the problem drug, no longer has cravings, and experiences few, if any, side effects; and a maintenance phase when a patient is doing well on a steady dose of buprenorphine. The length of time of the maintenance phase is tailored to each patient and could be indefinite. Once an individual is stabilized, an alternative approach would be to go into a medically supervised withdrawal, which makes the transition from a physically dependent state smoother. People then can engage in further rehabilitation—with or without MAT—to prevent a possible relapse. Ideal candidates for opioid dependency treatment with buprenorphine have an opioid use disorder diagnosis, are willing to follow safety precautions for the treatment, have been cleared of any health conflicts with using the drug and have reviewed other treatment options before agreeing to buprenorphine treatment.

Buprenorphine Based MAT Programs

Programs that provide specialized treatment services for individuals who have chronic skin wounds such as pressure sores or ulcerations associated with diabetes and peripheral vascular disease that have resisted other forms of treatment.

Wound Clinics

Programs that identify individuals who have contracted tuberculosis by administering chest x-rays; the Mantoux test, the von Pirquet test or the Vollmer patch test, all of which determine the presence of a tuberculosis infection based on a local inflammatory reaction to a sample of the bacillus which has been injected or rubbed into the skin; or other screening tools.

Tuberculosis Screening

Programs that provide counseling services for individuals at risk for contracting or transmitting the HIV virus with the objective of supporting their ability to make behavior changes that will reduce their risk of acquiring or transmitting HIV. Counseling involves a personal risk assessment, development of a personalized action plan and the decision to seek an HIV test. Individuals who have a history of injection drug use, unprotected intercourse or sexual contact, sexual activity at a young age, multiple sex partners, sexually transmitted infection, and/or sex trade work are considered to be at high or increased risk and are targets for prevention counseling.

AIDS/HIV Prevention Counseling

Programs that distribute Narcan or other similar substances that block the effects of opiates such as heroin, morphine, codeine, OxyContin, methadone, fentanyl and Vicodin but cannot themselves be used to get a person high. Opiate antidotes can be used to reverse the effects of an opiate overdose including restoring breathing that has stopped or slowed down, and may be distributed to opiate users to reduce the number of deaths that occur from opiate overdose.

Opioid Antidote Distribution

Programs that administer tests which identify individuals who have been exposed to hepatitis A, B or C by detecting the presence of associated antigens, antibodies or genetic material (DNA). Hepatitis is an inflammation of the liver caused by a variety of agents including viral infection (hepatitis A virus, hepatitis B virus, hepatitis C virus and delta agents), bacterial invasion and physical and chemical agents. Hepatitis A and delta agent hepatitis are spread primarily from person to person via the fecal-oral route, but may occur by contact with water or food contaminated by the virus. Hepatitis B and C are spread by blood and serum-derived fluids and by direct contact with body fluids. Depending on the type of hepatitis involved, screening may be particularly recommended for persons who have traveled or worked in countries with high rates of infection, sexually active homosexual men, injecting and non-injecting illegal drug users, persons who work with infected primates in a laboratory setting, persons with chronic liver disease, persons with clotting disorders, blood bank and dialysis workers, dental hygienists, and other members of health care teams who come into contact with blood, body fluids or body tissue.